Dr. Reddy's Laboratories Launches Generic Semaglutide Injection in Canada, Marks Major Global Milestone
India-based pharmaceutical giant Dr. Reddy's Laboratories has announced the launch of its generic Semaglutide Injection in Canada, becoming one of the first companies to introduce the product in the Canadian market following approval from Health Canada.





















